Evaluation of the SpeeDx MG parC (Beta) PCR Assay for Rapid Detection of Mycoplasma genitalium Quinolone Resistance-Associated Mutations
- PMID: 32719034
- PMCID: PMC7512155
- DOI: 10.1128/JCM.01432-20
Evaluation of the SpeeDx MG parC (Beta) PCR Assay for Rapid Detection of Mycoplasma genitalium Quinolone Resistance-Associated Mutations
Keywords: Mycoplasma genitalium; SpeeDx; antimicrobial resistance; moxifloxacin; parC; quinolone.
References
-
- Sweeney EL, Trembizki E, Bletchly C, Bradshaw CS, Menon A, Francis F, Langton-Lockton J, Nimmo GR, Whiley DM. 2019. Levels of Mycoplasma genitalium antimicrobial resistance differ by both region and gender in the state of Queensland, Australia: implications for treatment guidelines. J Clin Microbiol 57:e01555-18. doi:10.1128/JCM.01555-18. - DOI - PMC - PubMed
-
- Deguchi T, Ito S, Yasuda M, Kondo H, Yamada Y, Nakane K, Mizutani K, Tsuchiya T, Yokoi S, Nakano M. 2017. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan. J Infect Chemother 23:648–650. doi:10.1016/j.jiac.2017.03.008. - DOI - PubMed
-
- Deguchi T, Ito S, Yasuda M, Sato Y, Uchida C, Sawamura M, Manda K, Takanashi M, Kiyota H. 2018. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. J Infect Chemother 24:861–867. doi:10.1016/j.jiac.2018.08.009. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources